Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-12-13
2011-12-27
Desai, Rita (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S018000, C514S279000
Reexamination Certificate
active
08084609
ABSTRACT:
The present invention is concerned with novel spiro-piperidine derivatives as V1a receptor antagonists, their manufacture, pharmaceutical compositions containing them and their use for the treatment of anxiety and depressive disorders and other diseases. The compounds of present invention are described with formula (I)wherein R1to R5, R5′, R7to R9, R7′, R8′, X and Y are as defined in the specification.
REFERENCES:
patent: 3370091 (1968-02-01), Archer et al.
patent: 3531467 (1970-09-01), Archer et al.
patent: 4209625 (1980-06-01), Ong et al.
patent: 5019587 (1991-05-01), Von Der Saal et al.
patent: 5670509 (1997-09-01), Evans et al.
patent: 5885999 (1999-03-01), Elliott et al.
patent: 7332501 (2008-02-01), Bissantz et al.
patent: 7498339 (2009-03-01), Bissantz et al.
patent: 2001/0039286 (2001-11-01), Dinnell et al.
patent: 2002/0052371 (2002-05-01), Fukami et al.
patent: 2004/0260100 (2004-12-01), Ku et al.
patent: 2008/0139554 (2008-06-01), Bissantz et al.
patent: 2008/0153863 (2008-06-01), Bissantz et al.
patent: 2008/0171760 (2008-07-01), Bissantz et al.
patent: 2008/0281103 (2008-11-01), Bissantz et al.
patent: 344634 (1989-12-01), None
patent: 0718280 (1996-06-01), None
patent: 722941 (1996-07-01), None
patent: 2019093 (2009-01-01), None
patent: 93/25527 (1993-12-01), None
patent: WO 94/07496 (1994-04-01), None
patent: WO 97/21704 (1997-06-01), None
patent: WO 99/29696 (1999-06-01), None
patent: 00/14067 (2000-03-01), None
patent: 00/25780 (2000-05-01), None
patent: 00/78731 (2000-12-01), None
patent: WO 01/14376 (2001-03-01), None
patent: 01/85725 (2001-11-01), None
patent: WO 02/28861 (2002-04-01), None
patent: 03/040141 (2003-05-01), None
patent: WO 03/045385 (2003-06-01), None
patent: WO 03/053939 (2003-07-01), None
patent: 2004/022528 (2004-03-01), None
patent: 2004/026855 (2004-04-01), None
patent: 2004/035549 (2004-04-01), None
patent: 2004/046118 (2004-06-01), None
patent: 2004/069809 (2004-08-01), None
patent: 2004/087699 (2004-10-01), None
patent: 2004/089470 (2004-10-01), None
patent: 2005/013996 (2005-02-01), None
patent: 2005/046682 (2005-05-01), None
patent: WO 2005/063745 (2005-07-01), None
patent: WO 2006/013048 (2006-02-01), None
patent: WO 2006/040329 (2006-04-01), None
patent: WO 2006/123242 (2006-11-01), None
patent: WO 2007/028638 (2007-03-01), None
patent: 2007/053452 (2007-05-01), None
patent: 2008/006103 (2008-01-01), None
patent: 2008/138753 (2008-11-01), None
patent: 2009/032861 (2009-03-01), None
Evans, B et al,Jour. Of Med. Chem., 35:(21) (1992) 3919-3927.
Ebner et al., Eur. J. Neurosci. vol. 15, pp. 384-388 (2002).
Bielsky et al., Neuropsychopharmacology vol. 29, pp. 483-493 (2004).
Michelini et al., Ann. NY Acad. Sci. vol. 897 pp. 198-211 (1999).
Vankerckhoven et al., Eur. J. Pharmacol. vol. 449, Issue 1-2, pp. 135-141 (2002).
Liebsch et al., Regulatory Peptides vol. 59, Issue 2, pp. 229-239 (1995).
Parham et al., J. Org. Chem. vol. 41, pp. 2628-2633 (1976).
Moltzen et al., J. of Medicinal Chemistry vol. 38(11) pp. 2009-2017 (1995).
Serradeil-Le-Gal et at, Elsevier vol. 139, 2002, pp. 197-210 XP001205440.
Elliott et al., Serine derived NK1 antagonists 1998, Bioorganic & Medicinal Chem. Letters, vol. 8, pp. 1851-1856.
Abdel-Magid et al., J. Org. Chem, 1996, vol. 61 pp. 3849-3862.
Mattson et al,. J. Org. Chem. vol. 55, 1990, pp. 2552-2554.
Lecointe et al., Journal of Peptide Research vol. 55, 2000 pp. 300-307.
Baeza et al., Synthesis 2005, pp. 2787-2797.
Deuchert et al., Chem. Ber. vol. 112, 1979 pp. 2045-2061.
Dejaegher et al., Synlett 2002 pp. 113-115.
Grisar et al., J. Med. Chem. vol. 16, 1973 pp. 885-893.
Brenner et al., J. Heterocyclic Chem. vol. 22, 1985 pp. 805-808.
Sasse et al., Bioorganic & Medicinal Chem. vol. 8, 2000 pp. 1139-1149.
Terrasson et al., Synthesis 2006 pp. 1858-1862.
Fryer et al., J. Heterocyclic Chem vol. 4, 1967 pp. 149-150.
Walker et al., J. Org. Chem. vol. 36, 1970 pp. 305-308.
Walser et al., J. Heterocyclic Chem. vol. 11, 1974 pp. 885-888.
Fryer et al., J. Heterocyclic Chem. vol. 14, 1977, pp. 1435-1437.
Clerici et al., J. Org. Chem. vol. 47, 1982 pp. 2852-2856.
Clerici et al., J. Org. Chem. vol. 58, 1993, pp. 2889-2893.
Pfoertner et al., Helv. Chim. Acta vol. 68, 1985 pp. 600-605.
Xiang et al., Bioorganic & Med. Chem. Letters, 2004, pp. 2987-2989 XP004841329.
Delgado et al., J. Org. Chem. vol. 10, 1993, pp. 2862-2866.
Dorwald, F. A., Side Reactions in Organic Synthesis, 2005 pp. 8-9.
Genin et al., Design & Synthesis of BHAP, 1995, pp. 1875-1880.
Office Action Issued Mar. 8, 2011—in corresponding U.S. Appl. No. 11/964,993, filed Jan. 7, 2008.
Office Action Issued Feb. 14, 2011—in corresponding U.S. Appl. No. 11/969,983, filed Jan. 7, 2008.
Office Action Issued Feb. 1, 2011—in corresponding U.S. Appl. No. 11/960,823, filed Dec. 20, 2007.
Office Action Issued Feb. 1, 2011—in corresponding U.S. Appl. No. 11/960,799, filed Dec. 20, 2007.
Office Action Issued Jan. 19, 2011—in corresponding U.S. Appl. No. 11/947,953, filed Nov. 30, 2007.
Office Action Issued Feb. 2, 2011—in corresponding U.S. Appl. No. 11/960,779, filed Dec. 20, 2007.
Office Action Issued Jan. 21, 2011—in corresponding U.S. Appl. No. 11/947,967, filed Nov. 30, 2007.
Office Action Issued Jan. 20, 2011—in corresponding U.S. Appl. No. 11/947,934, filed Nov. 30, 2007.
Alfaidy et al., J. Clin. Invest. vol. 100, No. 10 pp. 2437-2442 (1997).
Office Action Issued Jan. 19, 2011—in corresponding U.S. Appl. No. 11/955,466, filed Dec. 13, 2007.
Office Action Issued Jan. 20, 2011—in corresponding U.S. Appl. No. 11/955,460, filed Dec. 13, 2007.
English Translation of Korean Office Action, 1992.
(Translation of Chinese Office Action in Corres. Pat. Appl. 200780046736.0 May 11, 2011).
Dhar et al., Bioorganic & Medicinal Chemistry Letters (XP002522864), 12(12):3125-3128 ( 2002).
Paul et al., Jour. of Medicinal Chemistry (XP002522865), 36(19):2716-2725 ( 1999).
Bissantz Caterina
Grundschober Christophe
Masciadri Raffaello
Ratni Hasane
Rogers-Evans Mark
Desai Rita
Hoffman-La Roche Inc.
Johnston George W.
Prior Kimberly J.
Rocha-Tramaloni Patricia S.
LandOfFree
Spiropiperidine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spiropiperidine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spiropiperidine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4294595